Testimonials
Hear what our clients have to say.
“Working with Oxford University Biotech Society has been incredibly rewarding. The project has provided valuable information in line with our request, and the team have shown real depth of knowledge and understanding. We have been impressed by their skillset, specifically the motivation and enthusiasm with which they have approached all aspects of the project. Presentations have been prepared to a very high standard, delivered with precision and passion. Discussion points were successfully debated and clearly demonstrated a thorough and well-researched review of the specific field of study. Most definitely the entrepreneurs of the future. Congratulations to the entire team.“
“Working with Oxford University Biotech has been excellent and has aided us in gaining new insights into our research area. The team were knowledgeable, skilled, diligent and were able to apply themselves competently to a new research area and to meaningfully support our teams. OUBT had a multi-disciplinary team that produced high quality research. The end report was high quality and thoughtfully assembled. During project updates the team were capable of high quality interactions and came equipped with excellent presentations to support their findings. We will work with them again”
“We were delighted to work with the OUBT Consulting team on a comprehensive review of a rapidly growing oncology modality. The team delivered a thorough and well-structured assessment of the current research landscape, providing valuable insights that have significantly enhanced OBT’s understanding of the field and will help inform future strategic efforts. Throughout the project, the team demonstrated professionalism, analytical rigor, and an impressive ability to deliver a comprehensive assessment within a short timeframe. They were a pleasure to work with, bringing energy, enthusiasm, and thoughtful contributions throughout the engagement. We look forward to following the team’s continued success and future contributions to the biotech ecosystem.”
“We were delighted to work with the consultancy team from the Oxford University Biotech Society (OUBT) on an independent assessment of Seroxo’s LIT™ platform. Their work was exceptional in both scientific and commercial dimensions. The team demonstrated a deep understanding of the underlying immunology and clinical context, carefully evaluating LIT™’s potential applications in areas such as infection and sepsis monitoring, transplant medicine optimisation, and inflammatory disease monitoring. At the same time, they brought a highly professional business perspective, clearly analysing the technology’s market potential, adoption pathways, and strategic positioning. The quality of their research, analytical rigor, and clarity of communication were outstanding throughout the project. They were responsive, collaborative, and consistently delivered thoughtful insights that have strengthened our scientific and commercial strategies. We would highly recommend their services to any organisation seeking rigorous scientific evaluation combined with strong commercial and strategic analysis. They were also just a great team to work with!“
“Working with the OUBT Consulting team was a real pleasure. They were professional, curious, and highly capable, delivering a thoughtful and well-researched report that has already generated valuable conversations and interest across our network. The quality of their work and the collaboration throughout were excellent, and we would not hesitate to work with them again!”
“As a very early-stage company, it’s not always easy to open up about what you’re building (especially not in bio/medtech). The OUBT team approached us with real curiosity and a structured mindset, which made the conversations both easy and rewarding. It’s refreshing to see how seriously they take biotech and company building at all stages. Overall, a positive experience for us! We’re excited to see what the team goes on to do. This sort of student input is often uniquely creative and brings perspectives you don’t get elsewhere.”
Stealth Mode pre-clinical biotech company